232 related articles for article (PubMed ID: 32744970)
21. From Antibacterial to Antitumour Agents: A Brief Review on The Chemical and Medicinal Aspects of Sulfonamides.
Azevedo-Barbosa H; Dias DF; Franco LL; Hawkes JA; Carvalho DT
Mini Rev Med Chem; 2020; 20(19):2052-2066. PubMed ID: 32888265
[TBL] [Abstract][Full Text] [Related]
22. Sulfocoumarin-, Coumarin-, 4-Sulfamoylphenyl-Bearing Indazole-3-carboxamide Hybrids: Synthesis and Selective Inhibition of Tumor-Associated Carbonic Anhydrase Isozymes IX and XII.
Angapelly S; Sri Ramya PV; Angeli A; Supuran CT; Arifuddin M
ChemMedChem; 2017 Oct; 12(19):1578-1584. PubMed ID: 28940980
[TBL] [Abstract][Full Text] [Related]
23. Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII.
Chandak N; Ceruso M; Supuran CT; Sharma PK
Bioorg Med Chem; 2016 Jul; 24(13):2882-2886. PubMed ID: 27137360
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of coumarin derivatives with cytotoxic, antibacterial and antifungal activity.
Khan KM; Saify ZS; Khan MZ; Zia-Ullah ; Choudhary IM; Atta-Ur-Rahman ; Perveen S; Chohan ZH; Supuran CT
J Enzyme Inhib Med Chem; 2004 Aug; 19(4):373-9. PubMed ID: 15558956
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in coumarins and 1-azacoumarins as versatile biodynamic agents.
Kulkarni MV; Kulkarni GM; Lin CH; Sun CM
Curr Med Chem; 2006; 13(23):2795-818. PubMed ID: 17073630
[TBL] [Abstract][Full Text] [Related]
26. Recent developments of C-4 substituted coumarin derivatives as anticancer agents.
Dandriyal J; Singla R; Kumar M; Jaitak V
Eur J Med Chem; 2016 Aug; 119():141-68. PubMed ID: 27155469
[TBL] [Abstract][Full Text] [Related]
27. Coumarins: old compounds with novel promising therapeutic perspectives.
Riveiro ME; De Kimpe N; Moglioni A; Vázquez R; Monczor F; Shayo C; Davio C
Curr Med Chem; 2010; 17(13):1325-38. PubMed ID: 20166938
[TBL] [Abstract][Full Text] [Related]
28. Coumarin hybrids as novel therapeutic agents.
Sandhu S; Bansal Y; Silakari O; Bansal G
Bioorg Med Chem; 2014 Aug; 22(15):3806-14. PubMed ID: 24934993
[TBL] [Abstract][Full Text] [Related]
29. Coumarin Hybrids: Promising Scaffolds in the Treatment of Breast Cancer.
Bhatia R; Rawal RK
Mini Rev Med Chem; 2019; 19(17):1443-1458. PubMed ID: 30854961
[TBL] [Abstract][Full Text] [Related]
30. New nimesulide derivatives with amide/sulfonamide moieties: Selective COX-2 inhibition and antitumor effects.
Güngör T; Ozleyen A; Yılmaz YB; Siyah P; Ay M; Durdağı S; Tumer TB
Eur J Med Chem; 2021 Oct; 221():113566. PubMed ID: 34077833
[TBL] [Abstract][Full Text] [Related]
31. Sulphonamide inhibition profile of
Urbanski LJ; Bua S; Angeli A; Kuuslahti M; Hytönen VP; Supuran CT; Parkkila S
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1834-1839. PubMed ID: 32972256
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial activity of two novel coumarin derivatives: 3-cyanonaphtho[1,2-(e)] pyran-2-one and 3-cyanocoumarin.
Zaha AA; Hazem A
New Microbiol; 2002 Apr; 25(2):213-22. PubMed ID: 12019728
[TBL] [Abstract][Full Text] [Related]
33. Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates.
Woo LL; Purohit A; Malini B; Reed MJ; Potter BV
Chem Biol; 2000 Oct; 7(10):773-91. PubMed ID: 11033081
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids.
Kraljević TG; Harej A; Sedić M; Pavelić SK; Stepanić V; Drenjančević D; Talapko J; Raić-Malić S
Eur J Med Chem; 2016 Nov; 124():794-808. PubMed ID: 27639370
[TBL] [Abstract][Full Text] [Related]
35. Coumarin derivatives with anticancer activities: An update.
Song XF; Fan J; Liu L; Liu XF; Gao F
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000025. PubMed ID: 32383190
[TBL] [Abstract][Full Text] [Related]
36. Synthetic and natural coumarins as potent anticonvulsant agents: A review with structure-activity relationship.
Keri RS; Budagumpi S; Balappa Somappa S
J Clin Pharm Ther; 2022 Jul; 47(7):915-931. PubMed ID: 35288962
[TBL] [Abstract][Full Text] [Related]
37. Design, Synthesis, and In Vitro Evaluation of Novel 3, 7-Disubstituted Coumarin Derivatives as Potent Anticancer Agents.
Wang Y; Liu H; Lu P; Mao R; Xue X; Fan C; She J
Chem Biol Drug Des; 2015 Oct; 86(4):637-47. PubMed ID: 25626768
[TBL] [Abstract][Full Text] [Related]
38. Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives.
Matos MJ; Gaspar A; Kachler S; Klotz KN; Borges F; Santana L; Uriarte E
J Pharm Pharmacol; 2013 Jan; 65(1):30-4. PubMed ID: 23215685
[TBL] [Abstract][Full Text] [Related]
39. [Studies on the synthesis of coumarin dervatives. XXI. On the preparation of 3-coumarinacetamide and 3,4-dihydro-2-oxo-2H-benzopyran-3-carboxamide derivatives].
Ichibagase H; Ichikawa M; Shimojo N
Yakugaku Zasshi; 1968 Jun; 88(6):755-60. PubMed ID: 5750306
[No Abstract] [Full Text] [Related]
40. Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies.
Thakur A; Singla R; Jaitak V
Eur J Med Chem; 2015 Aug; 101():476-95. PubMed ID: 26188907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]